<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Vet. Sci.</journal-id>
<journal-title>Frontiers in Veterinary Science</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Vet. Sci.</abbrev-journal-title>
<issn pub-type="epub">2297-1769</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fvets.2024.1380144</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Veterinary Science</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>FADD promotes type I interferon production to suppress porcine reproductive and respiratory syndrome virus infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Chang</surname> <given-names>Xiaobo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Mengqi</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Zhaopeng</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Lei</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2664482/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Gaiping</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Chang</surname> <given-names>Yafei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2645305/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hu</surname> <given-names>Jianhe</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2304527/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Postdoctoral Innovation Practice Base, College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology</institution>, <addr-line>Xinxiang</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology</institution>, <addr-line>Xinxiang</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>College of Veterinary Medicine, Henan Agricultural University</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001"><p>Edited by: Zhenbang Zhu, Yangzhou University, China</p></fn>
<fn fn-type="edited-by" id="fn0002"><p>Reviewed by: Kuan Zhao, Hebei Agricultural University, China</p><p>Wei Wen, Huazhong Agricultural University, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Yafei Chang, <email>changyafei1990@163.com</email></corresp>
<corresp id="c002">Jianhe Hu, <email>xxjianhe@126.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>11</volume>
<elocation-id>1380144</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Chang, Wang, Li, Wang, Zhang, Chang and Hu.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Chang, Wang, Li, Wang, Zhang, Chang and Hu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Porcine reproductive and respiratory syndrome (PRRS) is an epidemic animal infectious disease worldwide, causing huge economic losses to the global swine industry. Fas-associated death domain (FADD) was previously reported to be an adaptor protein that functions in transferring the apoptotic signals regulated by the death receptors. In the current study, we unravel its unidentified role in promoting type I interferon (IFN) production during PRRS virus (PRRSV) infection. We identified that FADD inhibited PRRSV infection via promotion of type I IFN transcription. Overexpression of FADD suppressed the replication of PRRSV, while knockout of FADD increased viral titer and nucleocapsid protein expression. Mechanistically, FADD promoted mitochondrial antiviral signaling protein (MAVS)-mediated production of IFN-&#x03B2; and some IFN-stimulated genes (ISGs). Furthermore, FADD exerted anti-PRRSV effects in a MAVS-dependent manner and increased the type I IFN signaling during PRRSV infection. This study highlights the importance of FADD in PRRSV replication, which may have implications for the future control of PRRS.</p>
</abstract>
<kwd-group>
<kwd>PRRSV</kwd>
<kwd>FADD</kwd>
<kwd>MAVS</kwd>
<kwd>type I IFN signaling</kwd>
<kwd>antiviral response</kwd>
</kwd-group>
<contract-num rid="cn1">222300420157</contract-num>
<contract-num rid="cn2">222102110387</contract-num>
<contract-num rid="cn3">32172862</contract-num>
<contract-num rid="cn4">222300420043</contract-num>
<contract-num rid="cn5">224200510024</contract-num>
<contract-sponsor id="cn1">Youth Fund of the Natural Science Foundation of Henan Province</contract-sponsor>
<contract-sponsor id="cn2">Henan Provincial Science and Technology Research Project</contract-sponsor>
<contract-sponsor id="cn3">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></contract-sponsor>
<contract-sponsor id="cn4">Outstanding Youth Foundation of Henan Scientific Committee</contract-sponsor>
<contract-sponsor id="cn5">Leading Talents of Scientific and Technological Innovation in the Central Plains</contract-sponsor>
<counts>
<fig-count count="8"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="44"/>
<page-count count="10"/>
<word-count count="5861"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Veterinary Infectious Diseases</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>Porcine reproductive and respiratory syndrome (PRRS), an important epidemic disease, characterized by late term gestation reproductive failure in sows and general respiratory symptoms in pigs of all ages and sexes, causing tremendous amounts of economic losses to the swine industry (<xref ref-type="bibr" rid="ref1 ref2 ref3 ref4">1&#x2013;4</xref>). PRRSV, the causative agent of PRRS, is an enveloped virus with 15&#x2009;kb positive-strand RNA genome containing at least 10 open reading frames (ORFs), belonging to the Arteriviridae family, Nidovirales order (<xref ref-type="bibr" rid="ref5 ref6 ref7">5&#x2013;7</xref>). PRRSV is divided into PRRSV-1 and PRRSV-2, and PRRSV-2 strains are predominantly prevalent in China (<xref ref-type="bibr" rid="ref8">8</xref>). In addition, PRRSV infection can trigger host innate immune response (<xref ref-type="bibr" rid="ref9">9</xref>).</p>
<p>Type I IFNs (IFN-&#x03B1;/&#x03B2;) play pivotal roles in antiviral response. Upon virus infection, viral nucleic acids as pathogen-associated molecular patterns (PAMPs) can be detected by the cellular receptors such as RNA sensor retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), which recruits the mitochondrial antiviral signaling (MAVS), leading to TBK1-dependent phosphorylation of IRF3, and transcription of type I IFNs and ISGs (<xref ref-type="bibr" rid="ref10">10</xref>, <xref ref-type="bibr" rid="ref11">11</xref>). Moreover, type I IFNs and numerous ISGs have been confirmed to have antiviral effects against PRRSV (<xref ref-type="bibr" rid="ref12 ref13 ref14 ref15">12&#x2013;15</xref>).</p>
<p>FADD, initially described as a key adaptor protein, interacted with the death receptors (DRs), such as FAS and the tumor necrosis factor receptor 1 (TNF-R1), leading to the recruitment and the activation of procaspase-8, and consequent apoptosis of the cell (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref17">17</xref>). In recent years, however, FADD has been reported to be involved in a variety of non-apoptotic processes, including cell cycle progression, embryonic development, hematopoiesis and lymphocyte cell cycle progression and survival (<xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref19">19</xref>). Besides, FADD has emerged as an actor of innate immunity and inflammation. In particular, FADD and RIPK1 could form the innateosome in response to viral RNA recognized by intracellular receptors, thereby regulating TBK1-mediated activation of IRF3 and IFN-&#x03B2; production (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref20">20</xref>). And several studies have shown that the replication of RNA viruses, such as VSV, ZIKV, influenza virus and encephalomyocarditis virus (EMCV), is greatly facilitated in FADD deficient human and mouse fibroblasts, which highlights the importance of FADD in the antiviral immune response (<xref ref-type="bibr" rid="ref21 ref22 ref23 ref24">21&#x2013;24</xref>). However, the roles and mechanism of FADD in response to PRRSV have not been elucidated.</p>
<p>In this study, we found that FADD overexpression restrained the replication of PRRSV, whereas FADD silence promoted PRRSV replication. Besides, FADD positively regulated MAVS-mediated type I IFN signaling pathway. More importantly, MAVS was essential for FADD to repress PRRSV replication, and the antiviral activity of FADD depended on the transcription of type I IFN. These findings may contribute to understanding the cellular proteins in the role of regulating PRRSV replication.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<title>Materials and methods</title>
<sec id="sec3">
<title>Cells and virus</title>
<p>MARC-145 (a PRRSV permissive cell line subcloned from MA-104) cells and HEK-293T cells were cultured in Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM, Solarbio) supplemented with 10% fetal bovine serum (FBS, Gibco), 100&#x2009;U/mL penicillin (Gibco) and 100&#x2009;&#x03BC;g/mL streptomycin (Gibco) at 37&#x00B0;C in a humidified atmosphere of 5% CO<sub>2</sub>. PRRSV strain BJ-4 (GenBank No. AF331831) stored in Henan Provincial Key Laboratory of Animal Immunology was a kind gift from Prof. Hanchun Yang (China Agricultural University).</p>
</sec>
<sec id="sec4">
<title>Antibodies and reagents</title>
<p>Rabbit anti-FADD antibody and Rabbit anti-MAVS antibody were purchased from Proteintech. Mouse anti-Flag M2 monoclonal antibody, mouse anti-c-Myc monoclonal antibody were purchased from Sigma-Aldrich. PRRSV N protein antibody was purchased from GeneTex. Mouse anti-&#x03B2;-actin monoclonal antibody was purchased from GenScript. The secondary antibodies conjugated to HRP were purchased from Proteintech. Polyinosinic-polycytidylic acid (polyI:C) was purchased from Sigma-Aldrich. Lipofectamine 2000 transfection reagent and Lipofectamine RNAiMAX transfection reagent were purchased from Invitrogen.</p>
</sec>
<sec id="sec5">
<title>Construction of plasmids</title>
<p>The cDNA of FADD was cloned into pCMV-Myc, named as FADD-Myc. The genes of RIG-I, MDA5, MAVS, TBK1 and IRF3 were cloned into pCMV-Flag, which were termed as RIG-I-Flag, MDA5-Flag, MAVS-Flag, TBK1-Flag and IRF3-Flag, respectively. The IFN-&#x03B2; luciferase reporter plasmid (IFN-&#x03B2;-Luc), has been constructed as previously described (<xref ref-type="bibr" rid="ref25">25</xref>). The pRL-TK (Promega), containing a Renilla-luciferase reporter gene, was used as an endogenous control in the dual luciferase reporter assay system. All primers used are listed in <xref ref-type="table" rid="tab1">Table 1</xref>.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Primers used for expression plasmid construction.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Primers</th>
<th align="left" valign="top">Sequences (5&#x2032; to 3&#x2032;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">FADD-F</td>
<td align="left" valign="top">CCCAAGCTTATGCGCGGTTCCCGGAGTT</td>
</tr>
<tr>
<td align="left" valign="top">FADD-R</td>
<td align="left" valign="top">CCGCTCGAGTCAGGATGCTTCGGAGGTGG</td>
</tr>
<tr>
<td align="left" valign="top">RIG-I-F</td>
<td align="left" valign="top">TCCCCCCGGGCATGACTACGGAGCAGCGGCGCAGCCT</td>
</tr>
<tr>
<td align="left" valign="top">RIG-I-R</td>
<td align="left" valign="top">ATCTGTCGACTCATTTGGCCATTTCTGCTGGAT</td>
</tr>
<tr>
<td align="left" valign="top">MDA5-F</td>
<td align="left" valign="top">CGCGGATCCATGTCGAATGGGTATTCCACAGAC</td>
</tr>
<tr>
<td align="left" valign="top">MDA5-R</td>
<td align="left" valign="top">CCGCTCGAGCTAATCCTCATCACTAAATAAACAGCA</td>
</tr>
<tr>
<td align="left" valign="top">MAVS-F</td>
<td align="left" valign="top">CCCAAGCTTATGCCGTTTGCTGAAGACAAGACCT</td>
</tr>
<tr>
<td align="left" valign="top">MAVS-R</td>
<td align="left" valign="top">CCGCTCGAGCTAGTGCAGGCGCCGCCGGTACATC</td>
</tr>
<tr>
<td align="left" valign="top">TBK1-F</td>
<td align="left" valign="top">CGCGGATCCATGCAGAGCACTTCTAATCATCT</td>
</tr>
<tr>
<td align="left" valign="top">TBK1-R</td>
<td align="left" valign="top">CCGCTCGAGCTAAAGACAGTCAACGTTGCGA</td>
</tr>
<tr>
<td align="left" valign="top">IRF3-F</td>
<td align="left" valign="top">CCCAAGCTTATGGGAACCCCAAAGCCACGGAT</td>
</tr>
<tr>
<td align="left" valign="top">IRF3-R</td>
<td align="left" valign="top">CCGCTCGAGTCAGGTCTCCCCAGGGCCCTGGAA</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec6">
<title>RNA interference</title>
<p>Small interfering RNAs (siRNA) targeting FADD (siFADD: 5&#x2032;-GGAAGAACGCAGAGAAGAATT-3&#x2032;), MAVS (siMAVS: 5&#x2032;-GCAUCUCUUCAGUACCCUUTT-3&#x2032;) and the non-target control siRNA (siNC: 5&#x2032;-UUCUCCGAACGUGUCACGUTT-3&#x2032;) were designed and synthesized by GenePharma. MARC-145 cells were transfected with 50&#x2009;nM siRNA using Lipofectamine RNAiMAX transfection reagent. Twenty-four hours later, the cells were infected with PRRSV at a multiplicity of infection (MOI) of 0.1. And then, the cells or the supernatants were harvested at the indicated times (24, 36 and 48&#x2009;h) for subsequent experiments.</p>
</sec>
<sec id="sec7">
<title>Quantitative real-time PCR analysis</title>
<p>Total RNAs were extracted using Cell/Tissue Total RNA Isolation Kit (Vazyme), and the reverse transcription cDNAs were prepared from total RNAs using the HiScript<sup>&#x00AE;</sup> III All-in-one RT SuperMix Perfect for qPCR (Vazyme). The cDNAs were amplified by quantitative real-time PCR (qPCR) using ChamQ Universal SYBR qPCR Master Mix (Vazyme). The relative mRNA level of gene expression was evaluated using the 2<sup>&#x2212;&#x0394;&#x0394;CT</sup> method with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA as an endogenous control. The primers for qPCR are listed in <xref ref-type="table" rid="tab2">Table 2</xref>.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Primers used for qPCR.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Primers</th>
<th align="left" valign="top">Forward primer (5&#x2032; to 3&#x2032;)</th>
<th align="left" valign="top">Reverse primer (5&#x2032; to 3&#x2032;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">ORF7</td>
<td align="left" valign="top">AAACCAGTCCAGAGGCAAGG</td>
<td align="left" valign="top">GCAAACTAAACTCCACAGTGTAA</td>
</tr>
<tr>
<td align="left" valign="top">FADD</td>
<td align="left" valign="top">GACCTCTTCTCCGTACTGCTGG</td>
<td align="left" valign="top">TAAATGCTGCACACAGGTCTTCTTC</td>
</tr>
<tr>
<td align="left" valign="top">IFN-&#x03B2;</td>
<td align="left" valign="top">ACGGCTCTTTCCATGAGCTAC</td>
<td align="left" valign="top">GTCAATGCAGCGTCCTCCTT</td>
</tr>
<tr>
<td align="left" valign="top">ISG15</td>
<td align="left" valign="top">CTGAAGGCAAAGATCGCCCA</td>
<td align="left" valign="top">GTCGTTCCTCACCAGGATGC</td>
</tr>
<tr>
<td align="left" valign="top">ISG56</td>
<td align="left" valign="top">AGGAAACACCCACTTCGGTC</td>
<td align="left" valign="top">CCTCTAGGCTGCCCTTTTGT</td>
</tr>
<tr>
<td align="left" valign="top">OAS1</td>
<td align="left" valign="top">TGGTGGAGACACAAAGGGTT</td>
<td align="left" valign="top">AACCATGTTGCTGATACATCCTG</td>
</tr>
<tr>
<td align="left" valign="top">MAVS</td>
<td align="left" valign="top">CTGCCTCACAGCAAGAGACCA</td>
<td align="left" valign="top">GTAGACACAGGCCACTTCGTC</td>
</tr>
<tr>
<td align="left" valign="top">GAPDH</td>
<td align="left" valign="top">GAAGGTGAAGGTCGGAGTCA</td>
<td align="left" valign="top">CATGTAAACCATGTAGTTGAGGTC</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec8">
<title>Dual-luciferase reporter assays</title>
<p>Luciferase assays were conducted by the Dual-Luciferase<sup>&#x00AE;</sup> Reporter Assay System according to Promega&#x2019;s instructions. In brief, MARC-145 cells or HEK-293T cells were transfected with indicated expression plasmids, IFN-&#x03B2; luciferase reporter plasmid and pRL-TK renilla luciferase reporter plasmid by using Lipofectamine 2000 transfection reagent (Invitrogen). At 36 hpt, the cells were transfected with polyI:C (10&#x2009;&#x03BC;g/mL) for 12&#x2009;h. PolyI:C, the synthetic analog of double-stranded RNA (dsRNA), is experimentally used to trigger type I IFN production (<xref ref-type="bibr" rid="ref26">26</xref>). Then, the transfected cells were lysed in passive lysis buffer and subjected to luciferase activity measurement using dual-luciferase reporter assay system (Promega).</p>
</sec>
<sec id="sec9">
<title>Western blot analysis</title>
<p>The treated or mock MARC-145 cells were harvested and washed three times with cold PBS, and then lysed in RIPA Buffer (Sigma-Aldrich) containing protease inhibitor cocktail (Roche). Protein concentration was determined using Micro BCA protein assay kit (Thermo Fisher Scientific). Equal amounts of protein lysates with SDS-PAGE loading buffer were run on 10% SDS-PAGE gels and transferred to 0.22&#x2009;&#x03BC;m PVDF membranes. Then membranes were blocked in 5% skim milk and incubated with the indicated primary antibody overnight at 4&#x00B0;C, followed by the incubation with HRP-conjugated secondary antibodies for 2&#x2009;h at room temperature. Subsequently, Luminescent signals were detected with SuperSignal<sup>&#x2122;</sup> chemiluminescent HRP substrates (Thermo Fisher Scientific). The relative levels of target proteins normalized to &#x03B2;-actin were analyzed using Image J software.</p>
</sec>
<sec id="sec10">
<title>Virus titration</title>
<p>Virus titers were determined according to a previous report (<xref ref-type="bibr" rid="ref27">27</xref>). Briefly, MARC-145 cells, grown in 96-well plates, were infected with 10-fold serial dilution of samples. After 1&#x2009;h incubation at 37&#x00B0;C, the supernatants were replaced with fresh DMEM containing 2% FBS. Five days post infection, the cytopathic effect (CPE) characterized by clumping and shrinkage of cells was visible in MARC-145 cells and the viral titers were calculated by 50% tissue culture infective dose (TCID<sub>50</sub>) according to the method of Reed-Muench (<xref ref-type="bibr" rid="ref28">28</xref>).</p>
</sec>
<sec id="sec11">
<title>Statistical analysis</title>
<p>All experiments were repeated independently at least three times. The experimental data were presented as group mean and standard deviation (SD) and analyzed by the unpaired two-tailed student <italic>t</italic>-test with GraphPad. The asterisks in the figures indicate significant differences (<sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001).</p>
</sec>
</sec>
<sec sec-type="results" id="sec12">
<title>Results</title>
<sec id="sec13">
<title>FADD overexpression suppresses PRRSV replication</title>
<p>In the previous study, we reported that FADD is a target of miR-382-5p increased during PRRSV infection (<xref ref-type="bibr" rid="ref29">29</xref>). To verify the biological significance of FADD during PRRSV infection, we examined the effect of FADD on PRRSV replication. FADD was overexpressed in the MARC-145 cells by transfection with FADD-Myc. As shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>, when FADD was overexpressed, the mRNA levels of PRRSV N gene were lower than those in control cells at 24&#x2013;48&#x2009;h (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Subsequently, we measured the viral titers from the supernatants of FADD overexpressed or control cells. Overexpression of FADD reduced PRRSV release as shown by TCID<sub>50</sub> assay (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Furthermore, FADD overexpression markedly decreased the abundance of PRRSV N protein (<xref ref-type="fig" rid="fig1">Figures 1C</xref>&#x2013;<xref ref-type="fig" rid="fig1">E</xref>), which indicated that FADD overexpression showed inhibitory effects on PRRSV.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Overexpression of FADD inhibits PRRSV replication. MARC-145 cells were transfected with FADD-Myc or control vector for 24&#x2009;h, and then infected with PRRSV at a MOI of 0.1 for another 24, 36 and 48&#x2009;h. <bold>(A)</bold> The RNA levels of PRRSV were assessed by using qPCR. <bold>(B)</bold> The viral titers in cell culture supernatant were assayed and presented by TCID<sub>50</sub>. <bold>(C)</bold> The expression levels of FADD and N protein of PRRSV were analyzed using western blotting. <bold>(D,E)</bold> The relative intensity ratios of FADD and N protein were also shown in this figure using Image J software. All experiments were repeated at least three times with similar results. <sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. The statistical significance of differences was determined using student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fvets-11-1380144-g001.tif"/>
</fig>
</sec>
<sec id="sec14">
<title>FADD knockdown promotes PRRSV infection</title>
<p>In contrast, we examined the effects of FADD knockdown on PRRSV infection. We used specific siRNA to down-regulate the expression of endogenous FADD, which could efficiently reduce the FADD expression (<xref ref-type="fig" rid="fig2">Figures 2A</xref>,<xref ref-type="fig" rid="fig2">D</xref>,<xref ref-type="fig" rid="fig2">E</xref>). Then MARC-145 cells transfected with siRNAs were infected with PRRSV for 24, 36 and 48&#x2009;h, compared with nontargeting control siRNA (siNC)-transfected cells, PRRSV RNA levels and viral titers in FADD knockdown cells increased markedly at 24, 36 and 48&#x2009;hpi (<xref ref-type="fig" rid="fig2">Figures 2B</xref>,<xref ref-type="fig" rid="fig2">C</xref>). Similarly, silencing of FADD significantly enhanced the expression levels of N protein (<xref ref-type="fig" rid="fig2">Figures 2D</xref>&#x2013;<xref ref-type="fig" rid="fig2">F</xref>). These data suggest FADD is involved in PRRSV infection and is a cellular antiviral factor against PRRSV.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>FADD knockdown promotes PRRSV infection. MARC-145 cells were transfected with siFADD or a nontargeting control (siNC) for 24&#x2009;h, then the cells transfected with siFADD or siNC were infected with PRRSV at a MOI of 0.1 for 24, 36, 48&#x2009;h. <bold>(A)</bold> The knockdown efficiency of FADD and <bold>(B)</bold> the mRNA levels of PRRSV ORF7 were examined by qPCR. <bold>(C)</bold> The virus titers were analyzed by TCID<sub>50</sub>. <bold>(D)</bold> The expression levels of N protein were detected by western blotting with a rabbit anti-PRRSV N protein polyclonal antibody. <bold>(E,F)</bold> The relative expression levels of FADD and N protein were analyzed by Image J software. The results are representative of three independent experiments (the means &#x00B1; SD). <sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. The statistical significance of differences was determined using student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fvets-11-1380144-g002.tif"/>
</fig>
</sec>
<sec id="sec15">
<title>FADD promotes type I IFN production following polyI:C stimulation</title>
<p>FADD and RIPK1 could form an innateosome in response to viral dsRNA and then regulate TBK1-mediated IFN-&#x03B2; production (<xref ref-type="bibr" rid="ref17">17</xref>). So next we wonder to know whether FADD could regulate polyI:C-mediated type I IFN production. Poly (I:C), the synthetic analog of double-stranded RNA (dsRNA), is experimentally used to trigger type I IFN production (<xref ref-type="bibr" rid="ref30">30</xref>). The results showed that FADD overexpression in MARC-145 cells increases the IFN-&#x03B2; promoter activity (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and the transcriptional levels of IFN-&#x03B2; triggered by polyI:C (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). These data suggest that FADD participates in promoting type I IFN signaling.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>FADD promotes ployI:C-mediated production of IFN-&#x03B2;. <bold>(A)</bold> HEK-293T cells were transfected with IFN-&#x03B2; reporter plasmid and FADD-Myc or control vector, and 36&#x2009;h later, the cells were transfected with polyI:C (10&#x2009;&#x03BC;g/mL) for 12&#x2009;h, and then the luciferase activities of IFN-&#x03B2; were assayed by dual-luciferase report assay. <bold>(B)</bold> MARC-145 cells were transfected with FADD-Myc or control vector for 36&#x2009;h, then transfected with polyI:C for 12&#x2009;h, the mRNA levels of IFN-&#x03B2; were measured by qPCR. The results are representative of three independent experiments (the means &#x00B1; SD). <sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 and <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01. The statistical significance of differences was determined using student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fvets-11-1380144-g003.tif"/>
</fig>
</sec>
<sec id="sec16">
<title>FADD promotes MAVS-mediated type I IFN signaling</title>
<p>Given that FADD governs polyI:C-triggered activation of IFN-&#x03B2;, we investigated the role and mechanism of FADD in the RLR-MAVS signaling pathway. HEK-293T cells were co-transfected with plasmids encoding FADD, components of the RIG-I pathway, and IFN-&#x03B2; reporter plasmid. The results showed that FADD greatly enhanced the IFN-&#x03B2; promoter activity induced by MAVS and TBK1 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). And the mRNA transcriptional levels of IFN-&#x03B2; were dramatically increased in FADD and MAVS co-transfected cells, mildly increased in FADD and IRF3 co-transfected cells (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Meanwhile, FADD also upregulated MAVS-induced the mRNA expressions of ISG15, ISG56 and OAS1 (<xref ref-type="fig" rid="fig4">Figures 4C</xref>&#x2013;<xref ref-type="fig" rid="fig4">E</xref>). Besides, the mRNA expressions of OAS1 were also increased by RIG-I and TBK1 in FADD-transfected cells (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Subsequently, cells were co-transfected with MAVS, IFN-&#x03B2; reporter plasmid, and different concentrations of FADD, and we found that FADD increased MAVS-induced IFN-&#x03B2; promoter activity (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) and the mRNA transcription levels of IFN-&#x03B2;, ISG15, ISG56 and OAS1 in a dose-dependent manner (<xref ref-type="fig" rid="fig5">Figures 5B</xref>&#x2013;<xref ref-type="fig" rid="fig5">E</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>FADD promotes MAVS-mediated type I IFN signaling. <bold>(A)</bold> HEK-293T cells were transfected with IFN-&#x03B2; reporter plasmid, FADD-Myc, and RIG-I, MDA5, MAVS, TBK1, or IRF3 plasmids. Luciferase assays were performed at 48&#x2009;h. <bold>(B&#x2013;E)</bold> MARC-145 cells were transfected with FADD-Myc and RIG-I, MDA5, MAVS, TBK1, or IRF3 plasmids. And 48&#x2009;h later, the transcriptional levels of IFN-&#x03B2; <bold>(B)</bold>, ISG15 <bold>(C)</bold>, ISG56 <bold>(D)</bold> and OAS1 <bold>(E)</bold> were detected by qPCR. The results are representative of three independent experiments (the means &#x00B1; SD). <sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. The statistical significance of differences was determined using student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fvets-11-1380144-g004.tif"/>
</fig>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>FADD promotes MAVS-mediated type I IFN signaling in a dose-dependent manner. <bold>(A)</bold> HEK-293T cells were transfected with MAVS, increasing amounts of FADD-Myc and IFN-&#x03B2; reporter plasmid, at 48&#x2009;hpt, the luciferase activities were analyzed using a dual-luciferase reporter assay. <bold>(B&#x2013;E)</bold> MARC-145 cells were transfected with MAVS and increasing amounts of FADD-Myc, the mRNA levels of IFN-&#x03B2; <bold>(B)</bold>, ISG15 <bold>(C)</bold>, ISG56 <bold>(D)</bold> and OAS1 <bold>(E)</bold> were detected by qPCR. The results are representative of three independent experiments (the means &#x00B1; SD). <sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. The statistical significance of differences was determined using student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fvets-11-1380144-g005.tif"/>
</fig>
<p>Since FADD could enhance MAVS-mediated type I IFN signaling, to identify whether MAVS is indispensable for FADD to regulate the production of type I IFN, MARC-145 cells were transfected with siMAVS, FADD-Myc, and IFN-&#x03B2; reporter plasmid, and 36&#x2009;h later, the cells were stimulated with polyI:C. As shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>, FADD promoted polyI:C-induced IFN-&#x03B2; and ISGs (ISG15, ISG56 and OAS1) expressions in siNC cells. Nevertheless, it could not increase polyI:C-mediated production of type I IFN and ISGs upon silencing of MAVS. Collectively, these results suggest that FADD positively regulates MAVS-mediated type I IFN signaling.</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>FADD promotes type I IFN signaling in a MAVS-dependent manner. <bold>(A)</bold> MARC-145 cells were transfected with IFN-&#x03B2; reporter plasmid, FADD-Myc, and siNC or siMAVS for 36&#x2009;h, then the cells were stimulated with polyI:C, and 12&#x2009;h later, the luciferase activities of IFN-&#x03B2; were assayed by dual-luciferase reporter assay. <bold>(B&#x2013;E)</bold> MARC-145 cells were transfected with FADD-Myc and siNC or siMAVS for 36&#x2009;h, and then the cells were stimulated with polyI:C, and 12&#x2009;h later, the mRNA levels of IFN-&#x03B2; <bold>(B)</bold>, ISG15 <bold>(C)</bold>, ISG56 <bold>(D)</bold> and OAS1 <bold>(E)</bold> were detected by qPCR. The results are representative of three independent experiments (the means &#x00B1; SD). <sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. The statistical significance of differences was determined using student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fvets-11-1380144-g006.tif"/>
</fig>
</sec>
<sec id="sec17">
<title>FADD inhibits PRRSV infection via enhancing MAVS-IFN signaling</title>
<p>In view of the fact that FADD possesses significant antiviral activity and enhances MAVS-mediated type I IFN signaling, to investigate whether the antiviral activity of FADD is dependent on MAVS, MARC-145 cells were transfected with siRNAs of MAVS (siMAVS) and FADD-Myc. As shown in <xref ref-type="fig" rid="fig7">Figure 7</xref>, marked reduction of MAVS expression was observed in the MAVS silenced cells (<xref ref-type="fig" rid="fig7">Figures 7A</xref>,<xref ref-type="fig" rid="fig7">D</xref>,<xref ref-type="fig" rid="fig7">E</xref>). And FADD could not decrease the PRRSV RNA levels (<xref ref-type="fig" rid="fig7">Figure 7B</xref>) and viral titers (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) in the MAVS-silenced cells. Meanwhile, there was no difference in PRRSV N protein between MAVS knockdown cells transfected with K-Myc and FADD-Myc (<xref ref-type="fig" rid="fig7">Figures 7D</xref>,<xref ref-type="fig" rid="fig7">F</xref>,<xref ref-type="fig" rid="fig7">G</xref>). These data indicated that the anti-PRRSV activity of FADD needs the involvement of MAVS.</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p>The antiviral activity of FADD is dependent on MAVS. MARC-145 cells were transfected with siMAVS and FADD-Myc, and 24&#x2009;h later, and the cells were infected with PRRSV at a MOI of 0.1 for 24&#x2009;h. Then, the cells were harvested, the silencing efficiency of MAVS <bold>(A)</bold> and RNA levels of PRRSV <bold>(B)</bold> were determined by qPCR. <bold>(C)</bold> The virus titers from cell supernatants were analyzed by TCID<sub>50</sub>. <bold>(D)</bold> The expression levels of N protein were detected by western blotting. <bold>(E&#x2013;G)</bold> The relative intensity ratios of MAVS, FADD and N protein were analyzed using Image J software. <sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001. The statistical significance of differences was determined using student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fvets-11-1380144-g007.tif"/>
</fig>
<p>In addition, we investigated whether FADD regulates the production of type I IFN and ISGs during PRRSV infection. MARC-145 cells were transfected with FADD-Myc or control vector for 24&#x2009;h, then the cells were infected with PRRSV for 24, 36 and 48&#x2009;h. Compared to control cells, cells with FADD overexpression significantly enhanced the expression of IFN-&#x03B2; at 24, 36 and 48&#x2009;h (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). Meanwhile, ISG15, ISG56 and OAS1 mRNA expressions were also increased in FADD-overexpressed cells (<xref ref-type="fig" rid="fig8">Figures 8B</xref>&#x2013;<xref ref-type="fig" rid="fig8">D</xref>). Overall, FADD promotes anti-PRRSV response through the regulation of IFN-&#x03B2; and interferon-stimulated gene expression mediated by MAVS.</p>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption>
<p>FADD enhances type I IFN signaling during PRRSV infection. MARC-145 cells were transfected with FADD-Myc or control vector for 24&#x2009;h, and infected with PRRSV at a MOI of 0.1 for another 24, 36 and 48&#x2009;h. Then, the cells were harvested, and the mRNA levels of IFN-&#x03B2; <bold>(A)</bold>, ISG15 <bold>(B)</bold>, ISG56 <bold>(C)</bold> and OAS1 <bold>(D)</bold> were detected by qPCR. <sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 and <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01. The statistical significance of differences was determined using student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fvets-11-1380144-g008.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec18">
<title>Discussion</title>
<p>PRRSV has emerged as one of the major threats to global pig industry since its outbreak in the late 1980s (<xref ref-type="bibr" rid="ref31">31</xref>). Although commercially available vaccinations are widely used, PRRSV is still not effectively controlled due to the antigenic drift. The relationship between PRRSV and its host is complex and delicate. On the one hand, PRRSV has evolved multiple strategies to suppress the production of type I IFNs. On the other hand, innate immunity exerts a key role in response to PRRSV (<xref ref-type="bibr" rid="ref32">32</xref>, <xref ref-type="bibr" rid="ref33">33</xref>). Here, a novel strategy is revealed in which the host protein FADD suppresses PRRSV by positively regulating host innate immune response.</p>
<p>The role of FADD in PRRSV infection was firstly investigated, and the results showed that overexpression of FADD could significantly suppress PRRSV replication (<xref ref-type="fig" rid="fig1">Figure 1</xref>), and silencing the expression of endogenous FADD by small interfering RNAs led to the promotion of PRRSV replication (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Subsequently, we demonstrated that FADD markedly enhances MAVS-mediated type I IFN signaling (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Furthermore, the ability of FADD to antagonize the replication of PRRSV is dependent on MAVS (<xref ref-type="fig" rid="fig7">Figure 7</xref>), and during PRRSV infection, FADD can promote the production of type I IFN and ISGs (ISG15, ISG56, and OAS1) (<xref ref-type="fig" rid="fig8">Figure 8</xref>). In conclusion, our study uncovered that FADD plays an important role in antiviral immune response.</p>
<p>FADD is an adaptor protein known to be crucial for the mammalian cell extrinsic pathway of apoptosis (<xref ref-type="bibr" rid="ref34">34</xref>). Apart from its critical role in death receptor signaling of apoptosis, FADD has emerged as a new actor in cancer development, inflammation, innate immunity, and virus infection. It has been reported that FADD<sup>&#x2212;/&#x2212;</sup> MEFs are highly sensitive to infection by many RNA viruses, including influenza virus, VSV and EMCV, due to defective interferon production (<xref ref-type="bibr" rid="ref21">21</xref>). In this study, we demonstrated that FADD plays an important role in inhibiting PRRSV replication, and it was the first time to give evidence that FADD was a host protein against PRRSV. Besides, many studies have demonstrated that PRRSV induces apoptosis both <italic>in vitro</italic> and <italic>in vivo</italic>. Apoptosis is often considered as an innate defense mechanism that limits virus infection by elimination of infected cells (<xref ref-type="bibr" rid="ref32">32</xref>). And PRRSV could increase TNFR1/FasL expression levels (<xref ref-type="bibr" rid="ref35">35</xref>), so maybe FADD has an important role in apoptosis after PRRSV infection. Moreover, we found that FADD inhibition of PRRSV replication depended on MAVS, and FADD could promote the MAVS-mediated production of IFN-&#x03B2; and downstream ISGs, which indicated that MAVS-mediated type I IFN pathway may play a key role in FADD repressing PRRSV replication.</p>
<p>MAVS is a critical adaptor in the RLR signaling pathway that links upstream recognition of viral RNA to downstream signal transduction in the antiviral response (<xref ref-type="bibr" rid="ref36">36</xref>). It is well known that MAVS aggregation is considered to be a hallmark of its activation and to be essential for its antiviral function. Ubiquitination of RIG-I was shown to be a critical element for it to activate MAVS, RIG-I binds to unanchored lysine-63 (K63) polyubiquitin chains and that this binding is important for MAVS aggregation and activation (<xref ref-type="bibr" rid="ref37">37</xref>). SNX8 was associated with VISA and increased the aggregation of VISA, leading to the activation of downstream signaling (<xref ref-type="bibr" rid="ref38">38</xref>). Phosphorylation and dephosphorylation have also been reported to play a critical role in antiviral innate immunity. c-Abl positively regulates the RLR signaling by phosphorylating MAVS at Y9, Y30, and Y71 (<xref ref-type="bibr" rid="ref39">39</xref>, <xref ref-type="bibr" rid="ref40">40</xref>). Besides, protein succinylation caused by succinyl-CoA is a newly discovered novel post-translational modification (<xref ref-type="bibr" rid="ref41">41</xref>). Sirtuin5 desuccinylates MAVS at K7 to diminish and antagonize the MAVS aggregation and antiviral response (<xref ref-type="bibr" rid="ref42">42</xref>). Given that the role of FADD in RLRs or MAVS-mediated upstream signaling is rarely explored, further studies on MAVS aggregation and post-translational modifications of MAVS by FADD need to be done to clarify the detailed mechanism of FADD regulating MAVS.</p>
<p>Besides, we also found that FADD could enhance OAS1 expression mediated by RIG-I and TBK1, but did not affect the expression of IFN-&#x03B2;, ISG15 and ISG56. Previous studies have identified that following viral infection, type I IFN signaling induces the production of the OAS family consisting of OAS1, OAS2, OAS3, and OAS-like (OASL) protein. The ubiquitin-like domains of OASL could substitute for K63-linked poly-ubiquitin and interact with the CARDs of RIG-I and thereby enhancing RIG-I signaling. And the crystal structure of the OAS-like domain shows a striking similarity with OAS1 (<xref ref-type="bibr" rid="ref43">43</xref>, <xref ref-type="bibr" rid="ref44">44</xref>), so the roles of FADD in RIG-I-OAS1 signaling axis remains to be further studied.</p>
<p>In summary, our study highlights the importance of FADD in PRRSV replication. We reported that FADD promotes MAVS-mediated type I IFN pathway and the expression of downstream genes. Besides, FADD inhibits PRRSV infection via MAVS-IFN pathway, which contribute to understanding the host antiviral mechanism, and may have implications for the future control of PRRS.</p>
</sec>
<sec sec-type="data-availability" id="sec19">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec sec-type="ethics-statement" id="sec20">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used. Ethical approval was not required for the studies on animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec sec-type="author-contributions" id="sec21">
<title>Author contributions</title>
<p>XC: Data curation, Formal analysis, Methodology, Writing &#x2013; review &#x0026; editing, Writing &#x2013; original draft. MW: Data curation, Formal analysis, Writing &#x2013; original draft. ZL: Data curation, Formal analysis, Writing &#x2013; original draft. LW: Formal analysis, Methodology, Writing &#x2013; original draft. GZ: Supervision, Writing &#x2013; original draft. YC: Supervision, Writing &#x2013; original draft. JH: Supervision, Writing &#x2013; original draft.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec22">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The research was supported by the Youth Fund of the Natural Science Foundation of Henan Province (222300420157), the Henan Provincial Science and Technology Research Project (222102110387), the National Natural Science Foundation of China (32172862), the Outstanding Youth Foundation of Henan Scientific Committee (222300420043), and the Leading Talents of Scientific and Technological Innovation in the Central Plains (224200510024).</p>
</sec>
<ack>
<p>The authors would like to thank Hanchun Yang for providing us with PRRSV strain BJ-4.</p>
</ack>
<sec sec-type="COI-statement" id="sec23">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albina</surname> <given-names>E</given-names></name></person-group>. <article-title>Epidemiology of porcine reproductive and respiratory syndrome (PRRS): An overview</article-title>. <source>Vet Microbiol</source>. (<year>1997</year>) <volume>55</volume>:<fpage>309</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0378-1135(96)01322-3</pub-id>, PMID: <pub-id pub-id-type="pmid">9220627</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holtkamp</surname> <given-names>DJ</given-names></name> <name><surname>Kliebenstein</surname> <given-names>JB</given-names></name> <name><surname>Neumann</surname> <given-names>EJ</given-names></name> <name><surname>Zimmerman</surname> <given-names>JJ</given-names></name> <name><surname>Rotto</surname> <given-names>HF</given-names></name> <name><surname>Yoder</surname> <given-names>TK</given-names></name> <etal/></person-group>. <article-title>Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers</article-title>. <source>J Swine Health Prod</source>. (<year>2013</year>) <volume>21</volume>:<fpage>72</fpage>&#x2013;<lpage>84</lpage>.</citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nieuwenhuis</surname> <given-names>N</given-names></name> <name><surname>Duinhof</surname> <given-names>TF</given-names></name> <name><surname>van Nes</surname> <given-names>A</given-names></name></person-group>. <article-title>Economic analysis of outbreaks of porcine reproductive and respiratory syndrome virus in nine sow herds</article-title>. <source>Vet Rec</source>. (<year>2012</year>) <volume>170</volume>:<fpage>225</fpage>. doi: <pub-id pub-id-type="doi">10.1136/vr.100101</pub-id>, PMID: <pub-id pub-id-type="pmid">22238201</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pejsak</surname> <given-names>Z</given-names></name> <name><surname>Stadejek</surname> <given-names>T</given-names></name> <name><surname>Markowska-Daniel</surname> <given-names>I</given-names></name></person-group>. <article-title>Clinical signs and economic losses caused by porcine reproductive and respiratory syndrome virus in a large breeding farm</article-title>. <source>Vet Microbiol</source>. (<year>1997</year>) <volume>55</volume>:<fpage>317</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0378-1135(96)01326-0</pub-id>, PMID: <pub-id pub-id-type="pmid">9220628</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>MY</given-names></name> <name><surname>Yoo</surname> <given-names>DW</given-names></name></person-group>. <article-title>Engineering the PRRS virus genome: updates and perspectives</article-title>. <source>Vet Microbiol</source>. (<year>2014</year>) <volume>174</volume>:<fpage>279</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vetmic.2014.10.007</pub-id>, PMID: <pub-id pub-id-type="pmid">25458419</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>CR</given-names></name> <name><surname>Griggs</surname> <given-names>TF</given-names></name> <name><surname>Gnanandarajah</surname> <given-names>J</given-names></name> <name><surname>Murtaugh</surname> <given-names>MP</given-names></name></person-group>. <article-title>Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arteriviruses</article-title>. <source>J Gen Virol</source>. (<year>2011</year>) <volume>92</volume>:<fpage>1107</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1099/vir.0.030213-0</pub-id>, PMID: <pub-id pub-id-type="pmid">21307222</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Music</surname> <given-names>N</given-names></name> <name><surname>Gagnon</surname> <given-names>CA</given-names></name></person-group>. <article-title>The role of porcine reproductive and respiratory syndrome (PRRS) virus structural and non-structural proteins in virus pathogenesis</article-title>. <source>Anim Health Res Rev</source>. (<year>2010</year>) <volume>11</volume>:<fpage>135</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S1466252310000034</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname> <given-names>MJ</given-names></name> <name><surname>Lefkowitz</surname> <given-names>EJ</given-names></name> <name><surname>King</surname> <given-names>AM</given-names></name> <name><surname>Harrach</surname> <given-names>B</given-names></name> <name><surname>Harrison</surname> <given-names>RL</given-names></name> <name><surname>Knowles</surname> <given-names>NJ</given-names></name> <etal/></person-group>. <article-title>Ratification vote on taxonomic proposals to the international committee on taxonomy of viruses (2016)</article-title>. <source>Arch Virol</source>. (<year>2016</year>) <volume>161</volume>:<fpage>2921</fpage>&#x2013;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00705-016-2977-6</pub-id>, PMID: <pub-id pub-id-type="pmid">27424026</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lunney</surname> <given-names>JK</given-names></name> <name><surname>Fang</surname> <given-names>Y</given-names></name> <name><surname>Ladinig</surname> <given-names>A</given-names></name> <name><surname>Chen</surname> <given-names>N</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Rowland</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>Porcine reproductive and respiratory syndrome virus (PRRSV): pathogenesis and interaction with the immune system</article-title>. <source>Annu Rev Anim Biosci</source>. (<year>2016</year>) <volume>4</volume>:<fpage>129</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-animal-022114-111025</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowie</surname> <given-names>AG</given-names></name> <name><surname>Unterholzner</surname> <given-names>L</given-names></name></person-group>. <article-title>Viral evasion and subversion of pattern-recognition receptor signalling</article-title>. <source>Nat Rev Immunol</source>. (<year>2008</year>) <volume>8</volume>:<fpage>911</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nri2436</pub-id>, PMID: <pub-id pub-id-type="pmid">18989317</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakhaei</surname> <given-names>P</given-names></name> <name><surname>Genin</surname> <given-names>P</given-names></name> <name><surname>Civas</surname> <given-names>A</given-names></name> <name><surname>Hiscott</surname> <given-names>J</given-names></name></person-group>. <article-title>RIG-I-like receptors: sensing and responding to RNA virus infection</article-title>. <source>Semin Immunol</source>. (<year>2009</year>) <volume>21</volume>:<fpage>215</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.smim.2009.05.001</pub-id>, PMID: <pub-id pub-id-type="pmid">19539500</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Overend</surname> <given-names>C</given-names></name> <name><surname>Mitchell</surname> <given-names>R</given-names></name> <name><surname>He</surname> <given-names>D</given-names></name> <name><surname>Rompato</surname> <given-names>G</given-names></name> <name><surname>Grubman</surname> <given-names>M</given-names></name> <name><surname>Garmendia</surname> <given-names>A</given-names></name></person-group>. <article-title>Recombinant swine beta interferon protects swine alveolar macrophages and MARC-145 cells from infection with porcine reproductive and respiratory syndrome virus</article-title>. <source>J Gen Virol</source>. (<year>2007</year>) <volume>88</volume>:<fpage>925</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1099/vir.0.82585-0</pub-id>, PMID: <pub-id pub-id-type="pmid">17325366</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>WM</given-names></name> <name><surname>Chevillotte</surname> <given-names>MD</given-names></name> <name><surname>Rice</surname> <given-names>CM</given-names></name></person-group>. <article-title>Interferon-stimulated genes: a complex web of host defenses</article-title>. <source>Annu Rev Immunol</source>. (<year>2014</year>) <volume>32</volume>:<fpage>513</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120231</pub-id>, PMID: <pub-id pub-id-type="pmid">24555472</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H</given-names></name> <name><surname>Bai</surname> <given-names>J</given-names></name> <name><surname>Fan</surname> <given-names>B</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>Q</given-names></name> <name><surname>Jiang</surname> <given-names>P</given-names></name></person-group>. <article-title>The interferon-induced Mx2 inhibits porcine reproductive and respiratory syndrome virus replication</article-title>. <source>J Interf Cytokine Res</source>. (<year>2016</year>) <volume>36</volume>:<fpage>129</fpage>&#x2013;<lpage>39</lpage>. doi: <pub-id pub-id-type="doi">10.1089/jir.2015.0077</pub-id>, PMID: <pub-id pub-id-type="pmid">26566027</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>J</given-names></name> <name><surname>Feng</surname> <given-names>N</given-names></name> <name><surname>Li</surname> <given-names>Z</given-names></name> <name><surname>Wang</surname> <given-names>P</given-names></name> <name><surname>Qi</surname> <given-names>Z</given-names></name> <name><surname>Liang</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>2&#x2032;,5&#x2032;-oligoadenylate synthetase 1(OAS1) inhibits PRRSV replication in MARC-145 cells</article-title>. <source>Antivir Res</source>. (<year>2016</year>) <volume>132</volume>:<fpage>268</fpage>&#x2013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.07.001</pub-id>, PMID: <pub-id pub-id-type="pmid">27395032</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carrington</surname> <given-names>P</given-names></name> <name><surname>Sandu</surname> <given-names>C</given-names></name> <name><surname>Wei</surname> <given-names>Y</given-names></name> <name><surname>Hill</surname> <given-names>J</given-names></name> <name><surname>Morisawa</surname> <given-names>G</given-names></name> <name><surname>Huang</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>The structure of FADD and its mode of interaction with procaspase-8</article-title>. <source>Mol Cell</source>. (<year>2006</year>) <volume>22</volume>:<fpage>599</fpage>&#x2013;<lpage>610</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2006.04.018</pub-id>, PMID: <pub-id pub-id-type="pmid">16762833</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mouasni</surname> <given-names>S</given-names></name> <name><surname>Tourneur</surname> <given-names>L</given-names></name></person-group>. <article-title>FADD at the crossroads between cancer and inflammation</article-title>. <source>Trends Immunol</source>. (<year>2018</year>) <volume>39</volume>:<fpage>1036</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.it.2018.10.005</pub-id>, PMID: <pub-id pub-id-type="pmid">30401514</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>NS</given-names></name> <name><surname>Dixit</surname> <given-names>V</given-names></name> <name><surname>Ashkenazi</surname> <given-names>A</given-names></name></person-group>. <article-title>Death receptor signal transducers: nodes of coordination in immune signaling networks</article-title>. <source>Nat Immunol</source>. (<year>2009</year>) <volume>10</volume>:<fpage>348</fpage>&#x2013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ni.1714</pub-id>, PMID: <pub-id pub-id-type="pmid">19295631</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname> <given-names>HQ</given-names></name> <name><surname>Wang</surname> <given-names>XS</given-names></name> <name><surname>Zha</surname> <given-names>DL</given-names></name> <name><surname>Gan</surname> <given-names>ZY</given-names></name> <name><surname>Cai</surname> <given-names>FF</given-names></name> <name><surname>Du</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>FADD is a key regulator of lipid metabolism</article-title>. <source>EMBO Mol Med</source>. (<year>2016</year>) <volume>8</volume>:<fpage>895</fpage>&#x2013;<lpage>918</lpage>. doi: <pub-id pub-id-type="doi">10.15252/emmm.201505924</pub-id>, PMID: <pub-id pub-id-type="pmid">27357657</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tourneur</surname> <given-names>L</given-names></name> <name><surname>Chiocchia</surname> <given-names>G</given-names></name></person-group>. <article-title>FADD: a regulator of life and death</article-title>. <source>Trends Immunol</source>. (<year>2010</year>) <volume>31</volume>:<fpage>260</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.it.2010.05.005</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balachandran</surname> <given-names>S</given-names></name> <name><surname>Thomas</surname> <given-names>E</given-names></name> <name><surname>Barber</surname> <given-names>G</given-names></name></person-group>. <article-title>A FADD-dependent innate immune mechanism in mammalian cells</article-title>. <source>Nature</source>. (<year>2004</year>) <volume>432</volume>:<fpage>401</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature03124</pub-id>, PMID: <pub-id pub-id-type="pmid">15549108</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balachandran</surname> <given-names>S</given-names></name> <name><surname>Venkataraman</surname> <given-names>T</given-names></name> <name><surname>Fisher</surname> <given-names>P</given-names></name> <name><surname>Barber</surname> <given-names>G</given-names></name></person-group>. <article-title>Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of IRF 7</article-title>. <source>J Immunol</source>. (<year>2007</year>) <volume>178</volume>:<fpage>2429</fpage>&#x2013;<lpage>39</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.178.4.2429</pub-id>, PMID: <pub-id pub-id-type="pmid">17277150</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michallet</surname> <given-names>M</given-names></name> <name><surname>Meylan</surname> <given-names>E</given-names></name> <name><surname>Ermolaeva</surname> <given-names>M</given-names></name> <name><surname>Vazquez</surname> <given-names>J</given-names></name> <name><surname>Rebsamen</surname> <given-names>M</given-names></name> <name><surname>Curran</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Tradd protein is an essential component of the RIG-like helicase antiviral pathway</article-title>. <source>Immunity</source>. (<year>2008</year>) <volume>28</volume>:<fpage>651</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2008.03.013</pub-id>, PMID: <pub-id pub-id-type="pmid">18439848</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>J</given-names></name> <name><surname>Sermwittayawong</surname> <given-names>D</given-names></name> <name><surname>Kim</surname> <given-names>H</given-names></name> <name><surname>Nandu</surname> <given-names>S</given-names></name> <name><surname>An</surname> <given-names>N</given-names></name> <name><surname>Erdjument-Bromage</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Fas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon production</article-title>. <source>J Biol Chem</source>. (<year>2011</year>) <volume>286</volume>:<fpage>6521</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M110.172288</pub-id>, PMID: <pub-id pub-id-type="pmid">21183682</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>XB</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Zhi</surname> <given-names>YB</given-names></name> <name><surname>Xing</surname> <given-names>GX</given-names></name> <name><surname>Zhao</surname> <given-names>D</given-names></name> <name><surname>Deng</surname> <given-names>RG</given-names></name> <etal/></person-group>. <article-title>Porcine reproductive and respiratory syndrome virus (PRRSV) could be sensed by professional beta interferon-producing system and had mechanisms to inhibit this action in MARC-145 cells</article-title>. <source>Virus Res</source>. (<year>2010</year>) <volume>153</volume>:<fpage>151</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virusres.2010.07.028</pub-id>, PMID: <pub-id pub-id-type="pmid">20692306</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>X</given-names></name> <name><surname>Shi</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>IFI16 inhibits porcine reproductive and respiratory syndrome virus 2 replication in a MAVS-dependent manner in MARC-145 cells</article-title>. <source>Viruses</source>. (<year>2019</year>) <volume>11</volume>:<fpage>1160</fpage>. doi: <pub-id pub-id-type="doi">10.3390/v11121160</pub-id>, PMID: <pub-id pub-id-type="pmid">31888156</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>XB</given-names></name> <name><surname>Yang</surname> <given-names>YQ</given-names></name> <name><surname>Gao</surname> <given-names>JC</given-names></name> <name><surname>Zhao</surname> <given-names>K</given-names></name> <name><surname>Guo</surname> <given-names>JC</given-names></name> <name><surname>Ye</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Annexin A2 binds to vimentin and contributes to porcine reproductive and respiratory syndrome virus multiplication</article-title>. <source>Vet Res</source>. (<year>2018</year>) <volume>49</volume>:<fpage>75</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13567-018-0571-5</pub-id>, PMID: <pub-id pub-id-type="pmid">30053894</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname> <given-names>LJ</given-names></name></person-group>. <article-title>A simple method of estimating fifty percent endpoints</article-title>. <source>Am J Epidemiol</source>. (<year>1938</year>) <volume>27</volume>:<fpage>493</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a118408</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>X</given-names></name> <name><surname>Shi</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Chen</surname> <given-names>J</given-names></name> <name><surname>Fan</surname> <given-names>X</given-names></name> <name><surname>Yang</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>miR-382-5p promotes porcine reproductive and respiratory syndrome virus (PRRSV) replication by negatively regulating the induction of type I interferon</article-title>. <source>FASEB J</source>. (<year>2020</year>) <volume>34</volume>:<fpage>4497</fpage>&#x2013;<lpage>511</lpage>. doi: <pub-id pub-id-type="doi">10.1096/fj.201902031RRR</pub-id>, PMID: <pub-id pub-id-type="pmid">32037657</pub-id></citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>Y</given-names></name> <name><surname>Xu</surname> <given-names>F</given-names></name></person-group>. <article-title>Anticancer function of polyinosinic-polycytidylic acid</article-title>. <source>Cancer Biol Ther</source>. (<year>2010</year>) <volume>10</volume>:<fpage>1219</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.4161/cbt.10.12.13450</pub-id></citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>M</given-names></name> <name><surname>Lam</surname> <given-names>TTY</given-names></name> <name><surname>Hon</surname> <given-names>CC</given-names></name> <name><surname>Hui</surname> <given-names>RKH</given-names></name> <name><surname>Faaberg</surname> <given-names>KS</given-names></name> <name><surname>Wennblom</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Molecular epidemiology of PRRSV: a phylogenetic perspective</article-title>. <source>Virus Res</source>. (<year>2010</year>) <volume>154</volume>:<fpage>7</fpage>&#x2013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virusres.2010.08.014</pub-id>, PMID: <pub-id pub-id-type="pmid">20837072</pub-id></citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>An</surname> <given-names>T</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Su</surname> <given-names>C</given-names></name> <name><surname>Yoo</surname> <given-names>D</given-names></name></person-group>. <article-title>Molecular and cellular mechanisms for PRRSV pathogenesis and host response to infection</article-title>. <source>Virus Res</source>. (<year>2020</year>) <volume>286</volume>:<fpage>197980</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virusres.2020.197980</pub-id>, PMID: <pub-id pub-id-type="pmid">32311386</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>Y</given-names></name> <name><surname>Han</surname> <given-names>M</given-names></name> <name><surname>Kim</surname> <given-names>C</given-names></name> <name><surname>Calvert</surname> <given-names>JG</given-names></name> <name><surname>Yoo</surname> <given-names>D</given-names></name></person-group>. <article-title>Interplay between interferon-mediated innate immunity and porcine reproductive and respiratory syndrome virus</article-title>. <source>Viruses</source>. (<year>2012</year>) <volume>4</volume>:<fpage>424</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.3390/v4040424</pub-id>, PMID: <pub-id pub-id-type="pmid">22590680</pub-id></citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chinnaiyan</surname> <given-names>A</given-names></name> <name><surname>O'Rourke</surname> <given-names>K</given-names></name> <name><surname>Tewari</surname> <given-names>M</given-names></name> <name><surname>Dixit</surname> <given-names>V</given-names></name></person-group>. <article-title>FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis</article-title>. <source>Cell</source>. (<year>1995</year>) <volume>81</volume>:<fpage>505</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0092-8674(95)90071-3</pub-id>, PMID: <pub-id pub-id-type="pmid">7538907</pub-id></citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>H</given-names></name> <name><surname>Jeng</surname> <given-names>C</given-names></name> <name><surname>Lin</surname> <given-names>C</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Chang</surname> <given-names>C</given-names></name> <name><surname>Tsai</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>The involvement of Fas/FasL interaction in porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus co-inoculation-associated lymphocyte apoptosis in vitro</article-title>. <source>Vet Microbiol</source>. (<year>2007</year>) <volume>122</volume>:<fpage>72</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vetmic.2007.01.013</pub-id>, PMID: <pub-id pub-id-type="pmid">17321702</pub-id></citation></ref>
<ref id="ref36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>B</given-names></name> <name><surname>Gao</surname> <given-names>C</given-names></name></person-group>. <article-title>Regulation of MAVS activation through post-translational modifications</article-title>. <source>Curr Opin Immunol</source>. (<year>2018</year>) <volume>50</volume>:<fpage>75</fpage>&#x2013;<lpage>81</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.coi.2017.12.002</pub-id></citation></ref>
<ref id="ref37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname> <given-names>F</given-names></name> <name><surname>Sun</surname> <given-names>L</given-names></name> <name><surname>Zheng</surname> <given-names>H</given-names></name> <name><surname>Skaug</surname> <given-names>B</given-names></name> <name><surname>Jiang</surname> <given-names>QX</given-names></name> <name><surname>Chen</surname> <given-names>ZJ</given-names></name></person-group>. <article-title>MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response</article-title>. <source>Cell</source>. (<year>2011</year>) <volume>146</volume>:<fpage>448</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2011.06.041</pub-id>, PMID: <pub-id pub-id-type="pmid">21782231</pub-id></citation></ref>
<ref id="ref38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>W</given-names></name> <name><surname>Wei</surname> <given-names>J</given-names></name> <name><surname>Zhong</surname> <given-names>X</given-names></name> <name><surname>Zang</surname> <given-names>R</given-names></name> <name><surname>Lian</surname> <given-names>H</given-names></name> <name><surname>Hu</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>SNX8 modulates the innate immune response to RNA viruses by regulating the aggregation of VISA</article-title>. <source>Cell Mol Immunol</source>. (<year>2020</year>) <volume>17</volume>:<fpage>1126</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41423-019-0285-2</pub-id>, PMID: <pub-id pub-id-type="pmid">31511639</pub-id></citation></ref>
<ref id="ref39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Shi</surname> <given-names>Y</given-names></name> <name><surname>Wu</surname> <given-names>J</given-names></name> <name><surname>Qi</surname> <given-names>N</given-names></name></person-group>. <article-title>MAVS: a two-sided card mediating antiviral innate immune signaling and regulating immune homeostasis</article-title>. <source>Front Microbiol</source>. (<year>2021</year>) <volume>12</volume>:<fpage>12</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2021.744348</pub-id>, PMID: <pub-id pub-id-type="pmid">34566944</pub-id></citation></ref>
<ref id="ref40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>J</given-names></name> <name><surname>Liao</surname> <given-names>Y</given-names></name> <name><surname>Xiao</surname> <given-names>L</given-names></name> <name><surname>Wu</surname> <given-names>R</given-names></name> <name><surname>Zhao</surname> <given-names>S</given-names></name> <name><surname>Chen</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia</article-title>. <source>Cell Death Differ</source>. (<year>2016</year>) <volume>24</volume>:<fpage>276</fpage>&#x2013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1038/cdd.2016.121</pub-id>, PMID: <pub-id pub-id-type="pmid">28141795</pub-id></citation></ref>
<ref id="ref41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y</given-names></name> <name><surname>Gibson</surname> <given-names>G</given-names></name></person-group>. <article-title>Succinylation links metabolism to protein functions</article-title>. <source>Neurochem Res</source>. (<year>2019</year>) <volume>44</volume>:<fpage>2346</fpage>&#x2013;<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11064-019-02780-x</pub-id>, PMID: <pub-id pub-id-type="pmid">30903449</pub-id></citation></ref>
<ref id="ref42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Zhu</surname> <given-names>C</given-names></name> <name><surname>Zha</surname> <given-names>H</given-names></name> <name><surname>Tang</surname> <given-names>J</given-names></name> <name><surname>Rong</surname> <given-names>F</given-names></name> <name><surname>Chen</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>SIRT5 impairs aggregation and activation of the signaling adaptor MAVS through catalyzing lysine desuccinylation</article-title>. <source>EMBO J</source>. (<year>2020</year>) <volume>39</volume>:<fpage>e103285</fpage>. doi: <pub-id pub-id-type="doi">10.15252/embj.2019103285</pub-id>, PMID: <pub-id pub-id-type="pmid">32301534</pub-id></citation></ref>
<ref id="ref43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ibsen</surname> <given-names>M</given-names></name> <name><surname>Gad</surname> <given-names>H</given-names></name> <name><surname>Andersen</surname> <given-names>L</given-names></name> <name><surname>Hornung</surname> <given-names>V</given-names></name> <name><surname>Julkunen</surname> <given-names>I</given-names></name> <name><surname>Sarkar</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I Signaling</article-title>. <source>Nucleic Acids Res</source>. (<year>2015</year>) <volume>43</volume>:<fpage>5236</fpage>&#x2013;<lpage>48</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkv389</pub-id>, PMID: <pub-id pub-id-type="pmid">25925578</pub-id></citation></ref>
<ref id="ref44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leisching</surname> <given-names>G</given-names></name> <name><surname>Wiid</surname> <given-names>I</given-names></name> <name><surname>Baker</surname> <given-names>B</given-names></name></person-group>. <article-title>The association of OASL and type I interferons in the pathogenesis and survival of intracellular replicating bacterial species</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2017</year>) <volume>7</volume>:<fpage>196</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2017.00196</pub-id>, PMID: <pub-id pub-id-type="pmid">28580319</pub-id></citation></ref>
</ref-list>
</back>
</article>